Ptc Therapeutics (PTCT) Total Debt (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Total Debt of $849.7 million for Q2 2026, up 55.05% year-over-year from $548.0 million in Q2 2025, and up 178.56% quarter-over-quarter from $305.0 million in Q1 2026.
Ptc Therapeutics (PTCT) Total Debt (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Total Debt history runs 15 years deep, the most recent figure standing at $849.7 million for Q2 2026.
- In Q2 2026, Total Debt rose 55.05% year-over-year to $849.7 million; the TTM figure through Jun 2026 stood at $849.7 million (up 55.05% YoY), while the FY2025 annual figure was $573.3 million, up 5.53% from the prior year.
- Total Debt for Q2 2026 stood at $849.7 million, up from $305.0 million in the prior quarter.
- The five-year high for Total Debt was $849.7 million in Q2 2026, with the low at $286.3 million in Q3 2025.
- The 5-year median for Total Debt is $541.3 million (2024), against an average of $533.8 million.
- The sharpest annual moves came in 2023 and 2025: Total Debt surged 88.24% in 2023, then slumped 47.24% in 2025.
- Ptc Therapeutics' Total Debt stood at $643.9 million in 2022, then declined by 25.68% to $478.5 million in 2023, then increased by 13.52% to $543.2 million in 2024, then grew by 5.53% to $573.3 million in 2025, then jumped by 48.23% to $849.7 million in 2026.
- Business Quant data shows PTCT's Total Debt at $849.7 million in Q2 2026, $305.0 million in Q1 2026, and $573.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 849.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 849.73 Mn |
| Mar 31, 2026 | 305.04 Mn |
| Dec 31, 2025 | 283.00 Mn |
| Sep 30, 2025 | 286.32 Mn |
| Jun 30, 2025 | 548.03 Mn |
| Mar 31, 2025 | 533.95 Mn |
| Dec 31, 2024 | 543.23 Mn |
| Sep 30, 2024 | 542.72 Mn |
| Jun 30, 2024 | 539.80 Mn |
| Mar 31, 2024 | 511.61 Mn |
| Dec 31, 2023 | 478.53 Mn |
| Sep 30, 2023 | 679.02 Mn |
| Jun 30, 2023 | 677.99 Mn |
| Mar 31, 2023 | 669.97 Mn |
| Dec 31, 2022 | 643.87 Mn |
| Sep 30, 2022 | 360.71 Mn |
| Jun 30, 2022 | 432.37 Mn |
| Mar 31, 2022 | 352.12 Mn |
| Dec 31, 2021 | 431.43 Mn |
| Sep 30, 2021 | 334.26 Mn |